Trial intelligence / Profile preview

Comparison of SPSIPB vs SAPB on Postoperative Analgesia in VATS

NCT06546839Completed

Sponsor
Istanbul Medipol University
Start
Aug 2024
Primary completion
Jun 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, single-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Istanbul Medipol University. Primary endpoint: Opioid consumption (Fentanyl PCA) at 24 hours. Started Aug 2024; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT06546839.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06546839.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call